Skip to content

Clinical trials

Phase 1/2 Pancreatic Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1/2 Status: Unknown status Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20071
20081
20101
20111
20132
20141
20153
20162
20172
20185
20195
20201
20211
20222
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aronex Pharmaceuticals2
Chinese PLA General Hospital2
PersonGen BioTherapeutics (Suzhou) Co., Ltd.2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Asclepius Technology Company Group (Suzhou) Co., Ltd.1
Axcentua Pharmaceuticals AB1
Cantex Pharmaceuticals1
Changhai Hospital1
Coherent Biopharma (Hefei) Co., Ltd.1
Craig L Slingluff, Jr1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms37
Colorectal Neoplasms8
Carcinoma, Hepatocellular6
Colonic Neoplasms6
Ovarian Neoplasms5
Stomach Neoplasms5
Breast Neoplasms4
Carcinoma, Non-Small-Cell Lung4
Esophageal Neoplasms4
Liver Neoplasms4

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.